Clinical Trial Update: Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

View source ↗

Summary

A completed clinical trial examining exosomal and free extracellular RNAs and proteins as predictive biomarkers for HER2-targeted therapies in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Breast Cancer, HER2 Positive Breast Cancer | Status: COMPLETED